US tracker

S. 2658

Medication Affordability and Patent Integrity Act

Health, Education, Labor, and Pensions Committee · Sen. Maggie Hassan (D-NH)

28 July 2026 | Reported by committee (Health, Education, Labor, and Pensions, with an amendment in the nature of a substitute, without written report)

What's next: Floor scheduling (leadership decides if and when it gets a vote)

Summary: The bill would require pharmaceutical companies to submit certain information and communications to federal health and patent agencies when seeking approval for new drugs or maintaining approval for existing medications. This aims to increase transparency and potentially help the government better understand patent-related issues that may affect drug affordability.

[AI-Generated]

Posted 10 September 2026

As published — the exact text this tracker posted, kept verbatim for the record

S. 2658 | Medication Affordability and Patent Integrity Act | Sen. Maggie Hassan (D-NH) | Health, Education, Labor, and Pensions Committee 📅 28 July 2026 | 📋 Reported by committee (Health, Education, Labor, and Pensions, with an amendment in the nature of a substitute, without written report) What's next: Floor scheduling (leadership decides if and when it gets a vote) Summary: The bill would require pharmaceutical companies to submit certain information and communications to federal health and patent agencies when seeking approval for new drugs or maintaining approval for existing medications. This aims to increase transparency and potentially help the government better understand patent-related issues that may affect drug affordability. [AI-Generated]

Look it up on Congress.gov See the full path of S. 2658

A permanent record of a post published by BillTracking's US tracker. The facts are drawn from the official record; the reference above is the lookup key on Congress.gov. Spotted an error? accuracy@billtracking.org.